Publications by authors named "Abdul Rafeh Awan"
Objective: To examine the effectiveness of rivaroxaban compared to enoxaparin in patients diagnosed with cancer and venous thromboembolism.
Methods: A search of Pub Med, Scopus, and Google Scholar, from inception through April 2023 was conducted. Articles comparing rivaroxaban with enoxaparin in patients with cancer and VTE/PE/DVT were included.
Background And Objectives: Acute appendicitis is one of the most commonly encountered surgical emergencies on a global level. Due to the requirement of an immediate clinical diagnosis and the presence of limited resources, clinicians and diagnosticians refer to scoring systems to diagnose this condition, among which Alvarado and Tzanakis scoring systems are widely used. This meta-analysis aims to compare the diagnostic accuracy of these two systems.
View Article and Find Full Text PDFArticle Synopsis
- Zuranolone (SAGE-217) is a newly FDA-approved antidepressant for postpartum depression (PPD) and is currently being tested for its effectiveness in treating Major Depressive Disorder (MDD) and essential tremors (ET).
- A review of four clinical trials with 1,357 patients showed that Zuranolone significantly improved depression ratings (HAM-D, MADRS, HAM-A) compared to a placebo on the 15th day of treatment.
- While Zuranolone was associated with a higher response and remission rate, it also had a significant occurrence of treatment-emergent adverse events (TEAEs), indicating some safety concerns compared to placebo.